AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,829,348 | +16.5% | 813,031 | +113.7% | 0.00% | 0.0% |
| Q1 2024 | $2,427,769 | +520.8% | 380,528 | +526.6% | 0.00% | – |
| Q4 2023 | $391,101 | +58889.6% | 60,730 | -83.1% | 0.00% | – |
| Q1 2023 | $663 | +177.4% | 360,145 | +186.6% | 0.00% | – |
| Q4 2022 | $239 | -99.9% | 125,650 | +59.0% | 0.00% | – |
| Q3 2022 | $169,000 | -74.9% | 79,010 | -66.8% | 0.00% | – |
| Q2 2022 | $673,000 | -3.7% | 237,659 | +41.8% | 0.00% | – |
| Q1 2022 | $699,000 | -56.6% | 167,566 | -46.0% | 0.00% | -100.0% |
| Q4 2021 | $1,611,000 | -44.5% | 310,324 | -30.0% | 0.00% | -50.0% |
| Q3 2021 | $2,904,000 | -39.7% | 443,431 | -38.9% | 0.00% | -33.3% |
| Q2 2021 | $4,815,000 | +267.8% | 725,172 | +217.3% | 0.00% | +200.0% |
| Q1 2021 | $1,309,000 | +374.3% | 228,509 | +640.2% | 0.00% | – |
| Q4 2020 | $276,000 | -84.0% | 30,873 | -79.2% | 0.00% | -100.0% |
| Q3 2020 | $1,726,000 | -85.2% | 148,320 | -79.6% | 0.00% | -87.5% |
| Q2 2020 | $11,651,000 | +148.4% | 726,841 | -7.2% | 0.02% | +45.5% |
| Q1 2020 | $4,691,000 | -47.5% | 783,164 | +15.8% | 0.01% | 0.0% |
| Q4 2019 | $8,930,000 | -48.5% | 676,481 | -51.5% | 0.01% | -59.3% |
| Q3 2019 | $17,340,000 | +40.3% | 1,396,142 | +81.8% | 0.03% | +42.1% |
| Q2 2019 | $12,362,000 | -12.8% | 767,836 | +70.5% | 0.02% | -9.5% |
| Q1 2019 | $14,173,000 | +3590.9% | 450,362 | +3749.2% | 0.02% | +2000.0% |
| Q4 2018 | $384,000 | -64.6% | 11,700 | -67.5% | 0.00% | 0.0% |
| Q3 2018 | $1,084,000 | -72.3% | 35,958 | -75.4% | 0.00% | -80.0% |
| Q2 2018 | $3,910,000 | – | 145,945 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $136,192,769 | 90.76% |
| TFG Asset Management GP Ltd | 7,525,682 | $48,013,851 | 10.88% |
| STEMPOINT CAPITAL LP | 2,965,721 | $18,921,300 | 5.00% |
| Deep Track Capital, LP | 15,272,172 | $97,436,457 | 2.79% |
| Affinity Asset Advisors, LLC | 3,375,000 | $21,532,500 | 2.67% |
| Lynx1 Capital Management LP | 1,390,160 | $8,869,221 | 2.28% |
| Cormorant Asset Management, LP | 6,616,667 | $42,214,335 | 1.85% |
| Paradigm Biocapital Advisors LP | 6,425,803 | $40,996,623 | 1.44% |
| Frazier Life Sciences Management, L.P. | 4,623,324 | $29,496,807 | 1.24% |
| GREAT POINT PARTNERS LLC | 1,166,667 | $7,443,335 | 1.16% |